Ozempic Side Effects May Shrink Heart Muscles, Study Warns
Tests found Ozempic caused the hearts of mice to atrophy, leaving researchers unsure whether the loss of cardiac muscle mass may occur in humans as well.
Tests found Ozempic caused the hearts of mice to atrophy, leaving researchers unsure whether the loss of cardiac muscle mass may occur in humans as well.
The Court may soon allow future lawsuits over Ozempic, Wegovy, Mounjaro and other GLP-1s to be brought using a Short Form Complaint, adopting allegations from the MDL Master Complaint.
Side effects of Wegovy caused a West Virginia woman to develop severe gastrointestinal problems, ileus and the need for her gallbladder to be surgically removed.
New GLP-1 warnings will urge users to inform their doctors before surgery if they are taking the diabetes and weight loss drugs.
Court will examine general causation, along with other “cross cutting” issues, before selecting any individual Ozempic gastroparesis lawsuits for trial workup.
Researchers have found that users of Ozempic, Mounjaro and similar drugs are less likely to experience opioid overdoses or alcoholism.
Lawsuit indicates that the gastroparesis diagnosis from Ozempic was confirmed after plaintiff underwent a gastric emptying test, which is evidence not present in many other claims in the litigation.
California woman indicates areas of her stomach treated by CoolSculpting System began showing large, misshapen bulges, requiring additional surgeries.
Inadequate bowel prep due to side effects of Ozempic and Mounjaro carries significant risk of missed lesions, canceled procedures and other complications.
Novo Nordisk allegedly knew for years about the risk that Ozempic and Rybelsus may cause ileus and other severe gastrointestinal side effects, but failed to warn doctors or patients.